Lion Point Capital, Lp Portfolio Stock Holdings
Lion Point Capital, Lp disclosed 35 stock positions valued at approximately $16.7 million in its latest SEC 13F filing. The largest holdings include PRAXIS PRECISION MEDICINES I, MOONLAKE IMMUNOTHERAPEUTICS, and ROYALTY PHARMA PLC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 35
- Portfolio Value
- $16.7M
Holdings by Sector
Lion Point Capital, Lp Portfolio Holdings in Q1 2026
29 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | PRAX | Healthcare | 8.57% | 4,450 | - | - | $1,433,746 |
| MOONLAKE IMMUNOTHERAPEUTICS | MLTX | Healthcare | 7.52% | 67,500 | - | - | $1,258,200 |
| ROYALTY PHARMA PLC | RPRX | Other | 6.14% | 21,400 | - | - | $1,026,558 |
| MILESTONE PHARMACEUTICALS IN | MIST | Healthcare | 5.83% | 820,000 | +65,000 | +8.61% | $975,800 |
| GERON CORP | GERN | Healthcare | 5.15% | 578,000 | - | - | $861,220 |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 5.03% | 36,000 | - | - | $840,960 |
| ARDELYX INC | ARDX | Healthcare | 4.61% | 128,650 | - | - | $770,614 |
| FENNEC PHARMACEUTICALS INC | FENC | Healthcare | 4.13% | 112,434 | - | - | $691,469 |
| BENITEC BIOPHARMA INC | BNTC | Healthcare | 3.95% | 62,000 | - | - | $660,300 |
| SAREPTA THERAPEUTICS INC | SRPT | Healthcare | 3.71% | 28,500 | - | - | $620,160 |
| DISC MEDICINE INC | IRON | Healthcare | 3.10% | 8,100 | - | - | $517,914 |
| CUE BIOPHARMA INC | CUE | Healthcare | 3.03% | 2,202,854 | - | - | $506,436 |
| COMPASS PATHWAYS PLC | CMPS | Healthcare | 2.64% | 80,000 | +22,000 | +37.93% | $442,400 |
| LANTHEUS HLDGS INC | LNTH | Healthcare | 2.49% | 5,500 | - | - | $417,175 |
| JASPER THERAPEUTICS INC | JSPR | Healthcare | 2.44% | 465,000 | - | - | $407,433 |
| HUMACYTE INC | HUMA | Healthcare | 2.36% | 650,000 | +150,000 | +30.00% | $394,355 |
| VIATRIS INC | VTRS | Healthcare | 2.24% | 27,700 | - | - | $374,227 |
| KURA ONCOLOGY INC | KURA | Healthcare | 2.24% | 46,000 | - | - | $373,980 |
| BRIDGEBIO PHARMA INC | BBIO | Healthcare | 2.22% | 5,000 | - | - | $371,300 |
| DYNE THERAPEUTICS INC | DYN | Healthcare | 1.95% | 18,000 | - | - | $326,340 |
| ROCKET PHARMACEUTICALS INC | RCKT | Healthcare | 1.84% | 86,000 | - | - | $307,880 |
| PACIRA BIOSCIENCES INC | PCRX | Healthcare | 1.82% | 13,500 | - | - | $305,100 |
| EDGEWISE THERAPEUTICS INC | EWTX | Healthcare | 1.71% | 9,100 | - | - | $286,650 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 1.70% | 10,500 | - | - | $284,445 |
| JANUX THERAPEUTICS INC | JANX | Healthcare | 1.58% | 19,000 | - | - | $264,100 |
| REGENXBIO INC | RGNX | Healthcare | 1.33% | 26,600 | - | - | $222,908 |
| AZENTA INC | AZTA | Healthcare | 1.22% | 9,700 | - | - | $204,961 |
| INNOVIVA INC | INVA | Healthcare | 1.14% | 8,200 | - | - | $191,060 |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | Healthcare | 0.74% | 5,250 | - | - | $123,690 |